P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)

Detalles Bibliográficos
Autores principales: Loschi, Michael, Rejto, Laszlo, Chuah, Hun, Caramella, Marianna, Hernández Rivas, Jesus, Sportoletti, Paolo, Dubruille, Viviane, Bellesso, Marcelo, Gröpper, Stefanie, Crodel, Carl, Qamoos, Hope, Socotch, Ashley, Huang, Zhuying, Wall, Sarah, Mcgreivy, Jesse, Rothbaum, Wayne P., Verstovsek, Srdan, Palandri, Francesca
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431408/
http://dx.doi.org/10.1097/01.HS9.0000971048.09624.cd
_version_ 1785091193663651840
author Loschi, Michael
Rejto, Laszlo
Chuah, Hun
Caramella, Marianna
Hernández Rivas, Jesus
Sportoletti, Paolo
Dubruille, Viviane
Bellesso, Marcelo
Gröpper, Stefanie
Crodel, Carl
Qamoos, Hope
Socotch, Ashley
Huang, Zhuying
Wall, Sarah
Mcgreivy, Jesse
Rothbaum, Wayne P.
Verstovsek, Srdan
Palandri, Francesca
author_facet Loschi, Michael
Rejto, Laszlo
Chuah, Hun
Caramella, Marianna
Hernández Rivas, Jesus
Sportoletti, Paolo
Dubruille, Viviane
Bellesso, Marcelo
Gröpper, Stefanie
Crodel, Carl
Qamoos, Hope
Socotch, Ashley
Huang, Zhuying
Wall, Sarah
Mcgreivy, Jesse
Rothbaum, Wayne P.
Verstovsek, Srdan
Palandri, Francesca
author_sort Loschi, Michael
collection PubMed
description
format Online
Article
Text
id pubmed-10431408
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104314082023-08-17 P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL) Loschi, Michael Rejto, Laszlo Chuah, Hun Caramella, Marianna Hernández Rivas, Jesus Sportoletti, Paolo Dubruille, Viviane Bellesso, Marcelo Gröpper, Stefanie Crodel, Carl Qamoos, Hope Socotch, Ashley Huang, Zhuying Wall, Sarah Mcgreivy, Jesse Rothbaum, Wayne P. Verstovsek, Srdan Palandri, Francesca Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10431408/ http://dx.doi.org/10.1097/01.HS9.0000971048.09624.cd Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Loschi, Michael
Rejto, Laszlo
Chuah, Hun
Caramella, Marianna
Hernández Rivas, Jesus
Sportoletti, Paolo
Dubruille, Viviane
Bellesso, Marcelo
Gröpper, Stefanie
Crodel, Carl
Qamoos, Hope
Socotch, Ashley
Huang, Zhuying
Wall, Sarah
Mcgreivy, Jesse
Rothbaum, Wayne P.
Verstovsek, Srdan
Palandri, Francesca
P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)
title P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)
title_full P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)
title_fullStr P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)
title_full_unstemmed P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)
title_short P1038: TL-895, A FIRST-IN-CLASS, COVALENT BRUTON TYROSINE KINASE INHIBITOR (BTKI) FOR THE TREATMENT OF MYELOFIBROSIS (MF) PATIENTS (PTS) WITH SEVERE THROMBOCYTOPENIA (PLATELETS (PLTS) <50 K/UL)
title_sort p1038: tl-895, a first-in-class, covalent bruton tyrosine kinase inhibitor (btki) for the treatment of myelofibrosis (mf) patients (pts) with severe thrombocytopenia (platelets (plts) <50 k/ul)
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431408/
http://dx.doi.org/10.1097/01.HS9.0000971048.09624.cd
work_keys_str_mv AT loschimichael p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT rejtolaszlo p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT chuahhun p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT caramellamarianna p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT hernandezrivasjesus p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT sportolettipaolo p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT dubruilleviviane p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT bellessomarcelo p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT gropperstefanie p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT crodelcarl p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT qamooshope p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT socotchashley p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT huangzhuying p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT wallsarah p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT mcgreivyjesse p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT rothbaumwaynep p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT verstovseksrdan p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul
AT palandrifrancesca p1038tl895afirstinclasscovalentbrutontyrosinekinaseinhibitorbtkiforthetreatmentofmyelofibrosismfpatientsptswithseverethrombocytopeniaplateletsplts50kul

Ejemplares similares